Acorda Therapeutics Strikes Creditor Deal On Ch. 11 Loan

By Rick Archer · May 3, 2024, 12:53 PM EDT

A New York judge on Friday gave final approval to Acorda Therapeutics' $60 million Chapter 11 financing package after hearing the drug developer and the lenders had resolved objections lodged by...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Acorda Therapeutics, Inc.

Case Number

Court

New York Southern

Nature of Suit

Date Filed

April 01, 2024

Recent Articles By Rick

November 21, 2024
Big Lots Seeks To Include Claims Against Execs In Asset Sale
November 20, 2024
FTX Examiner Wraps Probe, Clawback Try Goes Forward
November 19, 2024
Fluid Market Gets OK For Ch. 11 Loan, Dec. Asset Auction
November 18, 2024
Judge Will OK $88M Insurance Deal For Long Island Diocese
November 18, 2024
Spirit Airlines Files For Ch. 11 With Equity-Swap Plan
November 15, 2024
Swedish Debt Collector Intrum Files Prepack Ch. 11 In Texas
November 15, 2024
UAE Defense Contractor Facing Questions On Quitting Ch. 11
November 14, 2024
Judge Pondering 3rd-Party Releases In LaVie Ch. 11 Plan
November 13, 2024
Instant Brands Equity Owner Accused Of Lying To Lenders
November 13, 2024
Crypto Platform Celsius Reports $92M In Litigation Recoveries